Portal de Periódicos da CAPES

Prostate Cancer Early Detection, Version 2.2015

2015; National Comprehensive Cancer; Volume: 13; Issue: 12 Linguagem: Inglês

10.6004/jnccn.2015.0181

1540-1413

Peter R. Carroll, J. Kellogg Parsons, Gerald L. Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catàlona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth Etzioni, Thomas Farrington, George P. Hemstreet, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William T. Lowrance, Paul Maroni, James L. Mohler, Todd M. Morgan, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence Shaneyfelt, Marc C. Smaldone, Geoffrey A. Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Deborah A. Freedman-Cass,

Prostate Cancer Diagnosis and Treatment

Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.